Key Details
Price
$19.16Annual ROE
-56.93%Beta
1.02Events Calendar
Next earnings date:
May 1, 2025Recent quarterly earnings:
Feb 24, 2025Recent annual earnings:
Feb 24, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 28, 25 Goldman Sachs
BuyFeb 25, 25 HC Wainwright & Co.
BuyFeb 25, 25 Citizens Capital Markets
Market OutperformJan 21, 25 HC Wainwright & Co.
BuyJan 8, 25 Truist Securities
BuyDec 11, 24 Wells Fargo
OverweightDec 6, 24 Jefferies
BuyNov 18, 24 HC Wainwright & Co.
BuyNov 4, 24 JMP Securities
Market OutperformOct 31, 24 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Summit Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Summit Therapeutics?
- Does Summit Therapeutics pay dividends?
- What sector is Summit Therapeutics in?
- What industry is Summit Therapeutics in?
- What country is Summit Therapeutics based in?
- When did Summit Therapeutics go public?
- Is Summit Therapeutics in the S&P 500?
- Is Summit Therapeutics in the NASDAQ 100?
- Is Summit Therapeutics in the Dow Jones?
- When was Summit Therapeutics's last earnings report?
- When does Summit Therapeutics report earnings?
- Should I buy Summit Therapeutics stock now?
What is the ticker symbol for Summit Therapeutics?
The ticker symbol for Summit Therapeutics is NASDAQ:SMMT
Does Summit Therapeutics pay dividends?
No, Summit Therapeutics does not pay dividends
What sector is Summit Therapeutics in?
Summit Therapeutics is in the Healthcare sector
What industry is Summit Therapeutics in?
Summit Therapeutics is in the Biotechnology industry
What country is Summit Therapeutics based in?
Summit Therapeutics is headquartered in United States
When did Summit Therapeutics go public?
Summit Therapeutics's initial public offering (IPO) was on March 5, 2015
Is Summit Therapeutics in the S&P 500?
No, Summit Therapeutics is not included in the S&P 500 index
Is Summit Therapeutics in the NASDAQ 100?
No, Summit Therapeutics is not included in the NASDAQ 100 index
Is Summit Therapeutics in the Dow Jones?
No, Summit Therapeutics is not included in the Dow Jones index
When was Summit Therapeutics's last earnings report?
Summit Therapeutics's most recent earnings report was on Feb 24, 2025
When does Summit Therapeutics report earnings?
The next expected earnings date for Summit Therapeutics is May 1, 2025
Should I buy Summit Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions